Please login to the form below
European Haematology Association
This page shows the latest European Haematology Association news and features for those working in and with pharma, biotech and healthcare.
Regeneron's bispecific for lymphoma works in CAR-T failures
The new data for the highly-touted bispecific antibody – which targets both CD20 and CD3 – was presented at the European Haematology Association (EHA) congress in Amsterdam and showed very high response ... Roche’s mosunetuzumab candidate showed
Latest news
-
AZ’s Calquence threatens Imbruvica with new leukaemia data
New phase 3 data reported at the European Haematology Association (EHA) congress in Amsterdam over the weekend showed that Calquence (acalabrutinib) significantly prolonged the time relapsed or refractory CLL patients live
-
New trial results suggest CAR-T effects are durable in lymphoma
Updated results from the JULIET trial of the therapy in adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) – reported at the European Haematology Association (EHA) congress over the
-
Elotuzumab on track for multiple myeloma
BMS and AbbVie present phase II results at European Haematology Association meeting. ... Patients on the combination achieved a PFS of 33 months, with an objective response rate of more than 90 per cent, according to data presented at the European
-
FDA approves 'more effective' CML drug
Eighteen month follow-up results of the study were presented at the 46th annual American Society of Clinical Oncology (ASCO) meeting and the 15th Annual European Haematology Association (EHA) meeting.
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
What does the future hold for Light-chain Amyloidosis?
This followed the presentation of data from the Phase 3 ANDROMEDA study at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting and at the 26th European Haematology Association (EHA)
-
Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
This week, for example, was the European Haematology Association Congress, and typically there's 25, 000 people at one place with all the different companies there, you get the chance to ... I was on a patient association webinar the other day with a
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Biogen and Happify Health team up to create digital platform for MS patients
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Moderna to launch Innovation and Technology Center in the UK
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- How pharma found its voice – health communications for a brave new world
- The importance of beliefs in creative health engagement
- In recognition of the Anniversary of Stonewall, Nucleus Global brings attention and awareness to persistent health care inequities experienced by LGBTQIA+
- Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Almirall shares positive topline results from atopic dermatitis trials
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Pfizer to buy 8.1% stake in Valneva in support of joint Lyme disease programme
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
PMHub
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to...
Latest intelligence
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
- Report: Omnichannel advice for the life science industry
- In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...
